Yang, R., Elsaadi, S., Misund, K., Abdollahi, P., Vandsemb, E. N., Moen, S. H., Kusnierczyk, A., Slupphaug, G., Standal, T., Waage, A., Slørdahl, T. S., Rø, T. B., Rustad, E., Sundan, A., Hay, C., Cooper, Z., Schuller, A. G., Woessner, R., Borodovsky, A., Menu, E., Børset, M., & Sponaas, A. M. (2020). conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Journal for immunotherapy of cancer, 8(1), . http://access.bl.uk/ark:/81055/vdc_100127566625.0x000037